| Name | Title | Contact Details |
|---|
Sydnexis Inc. is a clinical stage biopharmaceutical company based in San Diego. They are currently evaluating their patented eyedrop formulation, SYD 101, in a Phase 3 clinical trial to decrease myopia progression in children.
Hoechst AG is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CanAm Bioresearch is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Developing high-value, global products for patients with significant unmet medical needs in niche indications